Find a Trial

Trial Summary



Notice: Undefined variable: ssqs in C:\xampp\htdocs\clinical_trials.php on line 35
Protocol No.PHO-COG-AAML1831
StatusOPEN TO ACCRUAL
Principal InvestigatorBatra, Sandeep
ScopeNational
PhasePhase III
Age GroupAdults and Children
TitleAAML1831, A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations.
Applicable Disease SitesLeukemia, other
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactJoy Rupenthal, Phone:
    Pager:
    Email: jhills1@iupui.edu